These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12672281)

  • 1. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
    Prados MD; Schold SC; Fine HA; Jaeckle K; Hochberg F; Mechtler L; Fetell MR; Phuphanich S; Feun L; Janus TJ; Ford K; Graney W
    Neuro Oncol; 2003 Apr; 5(2):96-103. PubMed ID: 12672281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma.
    Ford J; Osborn C; Barton T; Bleehen NM
    Eur J Cancer; 1998 Oct; 34(11):1807-11. PubMed ID: 9893673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
    Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
    J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas.
    Cloughesy TF; Black KL; Gobin YP; Farahani K; Nelson G; Villablanca P; Kabbinavar F; Viñeula F; Wortel CH
    Neurosurgery; 1999 Feb; 44(2):270-8; discussion 278-9. PubMed ID: 9932880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response and progression in recurrent malignant glioma.
    Hess KR; Wong ET; Jaeckle KA; Kyritsis AP; Levin VA; Prados MD; Yung WK
    Neuro Oncol; 1999 Oct; 1(4):282-8. PubMed ID: 11550320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
    Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
    J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Sep; 104(6):1281-7. PubMed ID: 16078267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
    Field KM; Simes J; Nowak AK; Cher L; Wheeler H; Hovey EJ; Brown CS; Barnes EH; Sawkins K; Livingstone A; Freilich R; Phal PM; Fitt G; ; Rosenthal MA
    Neuro Oncol; 2015 Nov; 17(11):1504-13. PubMed ID: 26130744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours.
    Thomas HD; Lind MJ; Ford J; Bleehen N; Calvert AH; Boddy AV
    Cancer Chemother Pharmacol; 2000; 45(4):284-90. PubMed ID: 10755316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
    Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
    Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.
    Chow KL; Gobin YP; Cloughesy T; Sayre JW; Villablanca JP; Viñuela F
    AJNR Am J Neuroradiol; 2000 Mar; 21(3):471-8. PubMed ID: 10730637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous carboplatin for recurrent malignant glioma: a phase II study.
    Yung WK; Mechtler L; Gleason MJ
    J Clin Oncol; 1991 May; 9(5):860-4. PubMed ID: 1849986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Vredenburgh J; Rich JN; Gururangan S; Badruddoja M; Herndon JE; Dowell JM; Friedman AH; Friedman HS
    Cancer; 2005 Jan; 103(2):329-38. PubMed ID: 15558802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group.
    Warren K; Jakacki R; Widemann B; Aikin A; Libucha M; Packer R; Vezina G; Reaman G; Shaw D; Krailo M; Osborne C; Cehelsky J; Caldwell D; Stanwood J; Steinberg SM; Balis FM
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):343-7. PubMed ID: 16408203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
    Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
    Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not.
    Grant R; Walker M; Hadley D; Barton T; Osborn C
    J Neurooncol; 2002 May; 57(3):241-5. PubMed ID: 12125987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.